---
title: "Sinovac: Signed a ten-year vaccine cooperation agreement with the Brazilian Ministry of Health, creating the largest international order for Chinese vaccines"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267452260.md"
description: "Sinovac has signed a ten-year vaccine cooperation agreement with the Brazilian Ministry of Health, becoming the first Chinese vaccine company to win the bid for this project. Sinovac will collaborate with Brazil's Tecpar Institute and Eurofarma to provide approximately 60 million doses of varicella and rabies vaccines to Brazil over the next ten years, with a contract amount exceeding 700 million USD, setting a record for the largest international order for a Chinese vaccine company"
datetime: "2025-11-26T03:58:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267452260.md)
  - [en](https://longbridge.com/en/news/267452260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267452260.md)
generator: "portal-rs"
---

# Sinovac: Signed a ten-year vaccine cooperation agreement with the Brazilian Ministry of Health, creating the largest international order for Chinese vaccines

According to SINOVAC's official WeChat account, on November 24 local time, Sinovac signed two PDP (Product Development Partnership) projects with the Brazilian Ministry of Health, becoming the first Chinese vaccine company to win this project. Sinovac will collaborate with local partners Tecpar Institute and Eurofarma to build a vaccine industry platform, helping Brazil enhance its domestic vaccine production capacity, and will provide a total of approximately 60 million doses of varicella vaccine and rabies vaccine to Brazil over the next 10 years, valued at over $700 million. This is the longest and largest international order in terms of contract value that a Chinese vaccine company has received to date

### Related Stocks

- [688185.CN](https://longbridge.com/en/quote/688185.CN.md)
- [06185.HK](https://longbridge.com/en/quote/06185.HK.md)
- [603392.CN](https://longbridge.com/en/quote/603392.CN.md)
- [300142.CN](https://longbridge.com/en/quote/300142.CN.md)

## Related News & Research

- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)
- [CanSino Biologics says China NMPA approves adsorbed tetanus vaccine NDA](https://longbridge.com/en/news/296476562.md)
- [CanSinoBIO spotlights meningococcal vaccine strategy at Asian pediatric infectious diseases congress](https://longbridge.com/en/news/296233860.md)
- [CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline](https://longbridge.com/en/news/296024108.md)
- [CanSino’s Td5cp Booster Wins Priority Review After NDA Acceptance in China](https://longbridge.com/en/news/296020241.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**